Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.5800
+0.00981.72%
Post-market: 0.58000.00000.00%19:34 EDT
Volume:12.28K
Turnover:7.12K
Market Cap:3.37M
PE:-0.23
High:0.5872
Open:0.5702
Low:0.5702
Close:0.5702
Loading ...
May 18, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2023

Major Issues Report

8-K - Current report
Apr 28, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 27, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 31, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 09, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 18, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2022

Major Issues Report

8-K - Current report
Oct 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 25, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 07, 2022

Major Issues Report

8-K - Current report